Clinical trial Recruiting at 2 sites Interventional Ages 19 to 90

EIT-guided PEEP for ARDS patients with higher lung recruitability

Official title: Effect of EIT-guided PEEP On Clinical Outcomes in ARDS Patients: a Multicenter Randomized Controlled Trial

Run by Southeast University, China · NCT06990477 · Data updated 2026-11-12

This trial tests whether using bedside electrical impedance tomography (EIT) to set PEEP helps adults with moderate-to-severe ARDS who show higher lung recruitability.

Quick facts

Study typeInterventional
Ages19 Years to 90 Years
SexAll
Enrollment2400 (estimated)
SponsorSoutheast University, China
Academic / other
Locations17 sites (Hefei, Anhui and 16 other locations)
StatusRecruiting
StartedMarch 13, 2026
Main results expectedDecember 31, 2029
Study endsFebruary 20, 2030
Registry record updatedJuly 10, 2026
Trial IDNCT06990477 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) with moderate-to-severe ARDS (PaO2/FiO2 ≤200 on PEEP ≥5 cmH2O), an RI ratio >0.5 measured within the prior 24 hours, ARDS diagnosis under 72 hours old, and expected to require mechanical ventilation beyond 48 hours are the ideal candidates.

Probably not a fit

Patients with low recruitability, contraindications to EIT (for example pacemakers or implanted defibrillators), those on ECMO, with short expected ventilation duration, or with severe comorbid organ failure are unlikely to benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study compares PEEP set using bedside electrical impedance tomography (EIT) with standard FiO2-PEEP table settings in mechanically ventilated adults with moderate-to-severe ARDS and higher recruitability. Patients eligible are adults within 72 hours of ARDS diagnosis, with a PaO2/FiO2 ≤200 and an RI ratio >0.5 measured within 24 hours. The EIT-guided approach individualizes PEEP based on regional ventilation distribution to try to improve lung recruitment while limiting overdistention. Clinical outcomes, including markers of oxygenation and ventilator-related complications, are compared between groups at participating ICUs.

Why it matters

Potential benefit: If successful, EIT-guided PEEP could improve oxygenation and reduce ventilator-induced lung injury for ARDS patients whose lungs are more recruitable.

How similar studies have gone: Small studies and pilot data, including prior work from these investigators, suggest EIT-guided PEEP can benefit selected patients, but larger definitive trials are still limited and results across studies have been mixed.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age≥18 years
2. Moderate-to-severe ARDS, defined by the ARDS Definition Task Force in the Berlin definition (partial pressure of arterial oxygen \[PaO2\]:FiO2 ratio ≤200 mmHg with a PEEP ≥5 cmH2O)
3. Diagnosis of ARDS less than 72 hours

Exclusion Criteria:

1. Expected to be mechanically ventilated for less than 48 hours
2. Severe chronic respiratory diseases requiring long-term home oxygen therapy or noninvasive MV
3. Undrained pneumothorax or subcutaneous emphysema
4. Contraindication to the use of EIT (pacemaker, automatic implantable cardioverter defibrillator, and implantable pumps)
5. Severe neuromuscular disease
6. Hemodynamic instability
7. Contraindications to hypercapnia, such as intracranial hypertension or acute coronary syndrome
8. Severe other organs dysfunction with a low expected survival (7 days) or palliative care
9. Severe liver disease (Child-Pugh Score ≥10)
10. Pregnancy
11. Refusal to sign the informed consent

Where it's running

  • Department of Critical Care Medicine, Zhongshan Hospital of Fudan University
    Shanghai, China Mainland, China
    Recruiting
  • Zhongda Hospital, School of Medicine, Southeast University
    Nanjing, Jiangsu, China
    Recruiting
  • Second Hospital of Anhui Medical University
    Hefei, Anhui, China
    Not yet recruiting
  • Department of Critical Care Medicine, Renji Hospital
    Shanghai, China Mainland, China
    Not yet recruiting
  • The First Affiliated Hospital of Guangzhou Medical University
    Guangzhou, Guangdong, China
    Not yet recruiting
  • Zhengzhou Central Hospital Affiliated to Zhengzhou University
    Zhengzhou, Henan, China
    Not yet recruiting
Show 11 more locations
  • The Affiliated Hospital of Hangzhou Normal University
    Hangzhou, Jiangsu, China
    Not yet recruiting
  • The Affiliated Hospital of Xuzhou Medical University
    Xuzhou, Jiangsu, China
    Not yet recruiting
  • The First Affiliated Hospital of Nanchang University
    Nanchang, Jiangxi, China
    Not yet recruiting
  • Qinghai University Affiliated Hospital
    Xining, Qinghai, China
    Not yet recruiting
  • First Affiliated Hospital of Xi'an Jiaotong University
    Xian, Shanxi, China
    Not yet recruiting
  • People's Hospital of Quzhou
    Quzhou, Zhejiang, China
    Not yet recruiting
  • Affiliated Beijing Chaoyang Hospital of Capital Medical University
    Beijing, China
    Not yet recruiting
  • Run Run Shaw Hospital affiliated to Zhejiang University School of Medicine
    Hangzhou, China
    Not yet recruiting
  • Ruijin Hospital Shanghai Jiaotong University School Of Medicine
    Shanghai, China
    Not yet recruiting
  • Asan Medical Center
    Seoul, South Korea
    Not yet recruiting
  • Taichung Veterans General Hospital
    Taichung, Taiwan
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Pulse Wave vs Saline Bolus EIT to measure lung perfusion in ARDS

    This study tests whether pulse wave EIT or saline bolus EIT can best show lung blood flow in ARDS patients on mechanical ventilation.

    Recruiting Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wuhan, Hubei · NCT07908368

  • Biorepository and endotyping study for ARDS patients

    This observational study tests whether creating a centralized ARDS biorepository and data set can help develop endotype and treatment-prediction tools for adults with ARDS.

    Recruiting Prenosis, Inc. · Urbana, Illinois · NCT07675265

  • BAL balance: ARDS through lung lavage and imaging to find different ARDS types

    This study tests how bronchoalveolar lavage fluid and chest CT imaging can reveal different ARDS subtypes in adults with ARDS or severe pneumonia in the ICU.

    Recruiting Medical University of Vienna · Vienna, State of Vienna · NCT07633366

  • Titrating PEEP in ARDS: Manual chest compression vs. electrical impedance tomography

    In adults with ARDS on mechanical ventilation, the study tests whether a simple manual chest compression method can set the right PEEP as well as electrical impedance tomography (EIT).

    Recruiting at 2 sites Centre Hospitalier Saint Joseph Saint Luc de Lyon · Créteil and 1 other locations · NCT07623590

  • Individualized PEEP Titration in ARDS Based on Lung Recruitment Potential

    This pilot study tests two personalized PEEP strategies in adults with ARDS to see which approach better supports breathing mechanics by using a recruitment potential measure.

    Recruiting Hospital Dr. Franco Ravera Zunino · Rancagua, Región del Libertador General Bernardo O’Higgins · NCT07603310

  • Single-dose inhaled rh-KGF-2 for ARDS in adults

    This trial tests whether a single inhaled dose of rh-KGF-2 helps adults with ARDS who are on ventilators, using three dose levels to see which is safest and potentially most effective.

    Recruiting Early Phase 1 Shanghai Zhongshan Hospital · Shanghai, Shanghai Municipality · NCT07558538

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.